Literature DB >> 1349568

Polymerase chain reaction-based genotyping for allotypic markers of immunoglobulin kappa shows allelic association of Km with kappa variable segment.

G Moxley1, R S Gibbs.   

Abstract

Allotypic markers of immunoglobulin kappa (Km) may be determined using a novel method of amplification of the constant segment (C kappa) (IGKC) by polymerase chain reaction (PCR) followed by restriction enzyme digestion. Restriction sites in the C kappa PCR product correlate with allotypic differences among Km(1), Km(1,2), and Km(3) alleles. An AccI site in the PCR product correlates with Km(3); and presence or absence of a MaeII site correlates with the Km(1) or Km(1,2) allele, respectively. Km allelic frequencies were determined in a Caucasian population and compared to genotypic frequencies of nearby polymorphic markers. Among unrelated individuals with rheumatoid arthritis (RA) and controls, there is no evidence of allelic association between CD8A and polymorphic markers of the immunoglobulin kappa region [a V kappa (IGKV) BglII polymorphism about 24 kb centromeric to C kappa, Km allotype, and a SacI polymorphism 3.5 kb telomeric to the C kappa segment]. Similarly, there is no allelic association of the SacI C kappa polymorphism with Km or with the BglII V kappa polymorphism. However, there is evidence of allelic association of V kappa B3 and Km, specifically between the V kappa BglII 2.2-kb allele and Km(3) and also between the V kappa 3.5-kb allele and Km(1,2). Therefore, Km typing by PCR-based methods suggests the presence of allelic association between polymorphisms within the coding region of the C kappa segment and the nearest V kappa segment.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1349568     DOI: 10.1016/0888-7543(92)90208-a

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  22 in total

1.  Immunoglobulin KM genes in Guillain-Barré syndrome.

Authors:  Janardan P Pandey; Christian A Vedeler
Journal:  Neurogenetics       Date:  2003-02-11       Impact factor: 2.660

2.  Immunoglobulin GM and KM genotypes in Korean patients with systemic lupus erythematosus.

Authors:  E B Lee; Y J Lee; D H Shin; Y M Choi; M H Park; J P Pandey; Y W Song
Journal:  Rheumatol Int       Date:  2006-08-31       Impact factor: 2.631

3.  Immunoglobulin allotype gene polymorphisms in systemic sclerosis: interactive effect of MHC class II and KM genes on anticentromere antibody production.

Authors:  H Kameda; J P Pandey; J Kaburaki; H Inoko; M Kuwana
Journal:  Ann Rheum Dis       Date:  1998-06       Impact factor: 19.103

4.  Immunoglobulin GM and KM allotypes and prevalence of anti-LKM1 autoantibodies in patients with hepatitis C virus infection.

Authors:  Paolo Muratori; Susan E Sutherland; Luigi Muratori; Alessandro Granito; Marcello Guidi; Georges Pappas; Marco Lenzi; Francesco B Bianchi; Janardan P Pandey
Journal:  J Virol       Date:  2006-05       Impact factor: 5.103

5.  Epistatic interactions between Fc (GM) and FcγR genes and the host control of human immunodeficiency virus replication.

Authors:  Raymond N Deepe; Emily Kistner-Griffin; Jeffrey N Martin; Steven G Deeks; Janardan P Pandey
Journal:  Hum Immunol       Date:  2011-12-11       Impact factor: 2.850

6.  Immunoglobulin KM allotypes are associated with the prevalence of autoantibodies to GD1a ganglioside, but not with susceptibility to the disease, in Japanese patients with Guillain-Barré syndrome.

Authors:  Janardan P Pandey; Michiaki Koga; Nobuhiro Yuki
Journal:  Neurogenetics       Date:  2005-10-29       Impact factor: 2.660

7.  Immunoglobulin genes and the acquisition of HIV infection in a randomized trial of recombinant adenovirus HIV vaccine.

Authors:  Janardan P Pandey; Aryan M Namboodiri; Shizhong Bu; Jean De Dieu Tapsoba; Alicia Sato; James Y Dai
Journal:  Virology       Date:  2013-04-11       Impact factor: 3.616

8.  Genetic markers of IgG influence the outcome of infection with hepatitis C virus.

Authors:  Janardan P Pandey; Aryan M Namboodiri; Yuqun Luo; Yuping Wu; Robert C Elston; David L Thomas; Hugo R Rosen; James J Goedert
Journal:  J Infect Dis       Date:  2008-11-01       Impact factor: 5.226

9.  Epistatic effects of immunoglobulin GM and KM allotypes on outcome of infection with hepatitis C virus.

Authors:  Janardan P Pandey; Jacquie Astemborski; David L Thomas
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

10.  Antigen-specific influence of GM/KM allotypes on IgG isotypes and association of GM allotypes with susceptibility to Plasmodium falciparum malaria.

Authors:  Hayder A Giha; Amre Nasr; Nnaemeka C Iriemenam; David Arnot; Marita Troye-Blomberg; Thor G Theander; Klavs Berzins; Gehad ElGhazali; Janardan P Pandey
Journal:  Malar J       Date:  2009-12-22       Impact factor: 2.979

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.